California Supreme Court Victory for Generic Fosamax Users

On September 25, 2013, the California Supreme Court denied the generic Fosamax manufacturers petition for review thereby upholding the June 13, 2013 Court of Appeal decision allowing people injured by generic Fosamax to go forward in the Courts and hold the generic manufacturers responsible.  In denying the generic manufacturers Petition, the Supreme Court let stand [...]

September 25th, 2013|Drug and Medical Device Litigation, Fosamax Osteoporosis Drug|Comments Off on California Supreme Court Victory for Generic Fosamax Users

Appellate Court Victory for Generic Fosamax Users

In a major victory for consumers who used the generic form of Fosamax, (Alendronate sodium) on June 13, 2013 the California Court of Appeal, Fourth Appellate District, Division Three ruled that people who used the generic Fosamax were not preempted by Federal law and the decision in PLIVA, Inc. v. Mensing (2011131 S.Ct. 2567 but [...]

June 13th, 2013|Drug and Medical Device Litigation, Fosamax Osteoporosis Drug|Comments Off on Appellate Court Victory for Generic Fosamax Users